We suspected this all along: people want to be engaged with their own healthcare. Our suspicions were confirmed by researchers in the U.S. in a study published in the European Journal of Human Genetics, as well as by researchers in the U.K. via survey results presented at the annual meeting of the European Society of Human Genetics.Read More
Up at 5AM: The 5AM Solutions Blog
At ASHG 2014, I had the pleasure of listening to the talks of Ajay Royyuru from IBM’s Computational Biology Center, and David Glazer from Google, during the ‘Separating Signal from Noise’ symposium.Read More
Last week, we did a post on curing cancer at the gene-level. But what about using genes to diagnose cancer? A feature story in the MIT Technology Review looks at research happening at Johns Hopkins University on that very possibility.
A few days ago I attended talks by Phil Bourne and John Wilbanks, both of whom are working on ways to make scientific data, including genetic information, more freely available for research purposes. Phil and John were speaking at an NIH conference called ‘Open Science: The Transparency Revolution’ (see agenda and videocast). Dr. Bourne is Associate Director for Data Science for NIH and Wilbanks is Chief Commons Officer at Sage Bionetworks. Bourne has only been in his position at NIH for about a month, so he outlined his goals, one of which was to create a data commons at the NIH where researchers could go to discover, access and analyze scientific data.
Craig Venter, the scientist who made a name for himself more than a decade ago by challenging the NIH-funded Human Genome Project, has a new venture. Last week he announced Human Longevity, Inc. The company, according to their press release, is “focused on extending the healthy, high performance human life span” and is going to “tackle the diseases associated with aging-related human biological decline”.